Fund comparison · from official SEC filings

BIPIX vs DXNLX: how much do they overlap?

BIOTECHNOLOGY ULTRASECTOR PROFUND and Direxion Monthly NASDAQ-100 Bull 1.25X Fund
Holdings overlap
11%
of assets, by weight
Shared positions
2
of 147 / 4 holdings
BIPIX expense ratio
1.52%
net, per year
DXNLX expense ratio
1.34%
net, per year
Shared holdings
Company
BIPIX
DXNLX
?
N/A
27.27%
9.09%
A
AGPXXINVESCO GVT & AGNCY-INST
2.01%
1.77%
Only in BIPIX
1
1JKAPELLIS PHARMACEUTICALS INC
1.32%
R
RVMDREVOLUTION MEDICINES INC
1.17%
T
TVTXTRAVERE THERAPEUTICS INC
1.15%
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.02%
T
TWSTTWIST BIOSCIENCE CORP
1.00%
S
SMMTSUMMIT THERAPEUTICS INC
0.99%
A
ALKSALKERMES PLC
0.98%
T
TGTXTG THERAPEUTICS INC
0.97%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.97%
B
BEAMBEAM THERAPEUTICS INC
0.94%
A
APGEAPOGEE THERAPEUTICS INC
0.89%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.87%
P
PRAXPRAXIS PRECISION MEDICINES I
0.86%
E
EXELEXELIXIS INC
0.86%
M
MIRMMIRUM PHARMACEUTICALS INC
0.85%
U
UTHRUNITED THERAPEUTICS CORP
0.84%
N
NTRANATERA INC
0.84%
C
CRSPCRISPR THERAPEUTICS AG
0.84%
C
CELCCELCUITY INC
0.84%
K
KRYSKRYSTAL BIOTECH INC
0.83%
P
PTGXPROTAGONIST THERAPEUTICS INC
0.83%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.82%
I
INCYINCYTE CORP
0.81%
C
CGONCG ONCOLOGY INC
0.81%
C
CYTKCYTOKINETICS INC
0.81%
Only in DXNLX
Q
QQQINVESCO QQQ TRUST SERIES 1
81.65%
F
FTIXXGLDMN SCHS FIN SQ TR-FST
7.48%
Hold BIPIX and DXNLX together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
BIPIX vs DXNLX: 11% holdings overlap — Unwrap.Fund